Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Science faculty’s subtle gender biases favor male students
2012 Standout
Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
2008
National HER2 proficiency test results using standardized quantitative controls: characterization of laboratory failures.
2008
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Tissue microarray technology in breast cancer HER2 diagnostics
2007
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Human Breast Cancer Tumor Models: Molecular Imaging of Drug Susceptibility and Dosing during HER2/neu-targeted Therapy
2008
Borderline HER‐2 breast cancer cases: Histochemical versus real‐time PCR analysis and impact of different cut‐off values
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Comprehensive immunohistochemical analysis of Her-2/neu oncoprotein overexpression in breast cancer: HercepTest™ (Dako) for manual testing and Her-2/neuTest 4B5 (Ventana) for Ventana BenchMark automatic staining system with correlation to results of fluorescence in situ hybridization (FISH)
2009
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Quantitative PCR and HER2 Testing in Breast Cancer
2008
Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancer.
2008
Tissue microarray technology in the routine assessment of HER‐2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization
2008
Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas
2009
Parenteral Anticoagulants
2012 Standout
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
2007 Standout
Comparison of Quantitative Immunofluorescence With Conventional Methods for HER2/ neu Testing With Respect to Response to Trastuzumab Therapy in Metastatic Breast Cancer
2008
National HER2 Proficiency Test Results Using Standardized Quantitative Controls: Characterization of Laboratory Failures
2008
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
2013
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds
2005
Rosuvastatin in the management of hyperlipidemia
2004
Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products
2010
Traditional Chinese Medicine for Cardiovascular Disease
2017 Standout
An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia
2001
The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast
1999
Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
1996
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Ulcerative Colitis
2011 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Determination ofHER2Amplification by In Situ Hybridization
2008
Mechanism of Action of Niacin
2008
The metabolic syndrome
2010 Standout
Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease
2003
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
1995 StandoutNatureNobel
Genetic instabilities in human cancers
1998 StandoutNature
Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin
2003
Statins and C‐Reactive Protein Levels
2007
Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification: Table 1
2011
Rosuvastatin for the Treatment of Hypercholesterolemia
2005
Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia
2000
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH
2010
A dose‐ranging study of a new, once‐daily, dual‐component drug product containing niacin extended‐release and lovastatin
2003
Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes
2002
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Adhesion in Mammary Development
2015
Traditional Chinese medication for cardiovascular disease
2014
Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction
2002
Inflammatory Bowel Disease and Smoking
2004
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 Standout
The metabolic syndrome
2005 Standout
Combined therapy in the treatment of dyslipidemia
2009
Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1
2007
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia**A complete list of participants in the Research Group and Publication Committee appears in the Appendix.
2002
Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study
2009
Valvular Heart Disease and Pregnancy
2005
Subclinical Atrial Fibrillation and the Risk of Stroke
2012
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins
1999
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid – a position paper developed by the European Consensus Panel on HDL-C*
2004
The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]
2003
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans
2008
Efficacy, Safety, and Tolerability of Once-Daily Niacin for the Treatment of Dyslipidemia Associated With Type 2 Diabetes<subtitle>Results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial</subtitle>
2002
Differential Expression of E-Cadherin in Lobular and Ductal Neoplasms of the Breast and Its Biologic and Diagnostic Implications
2001
Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia
2008
EMT: 2016
2016 Standout
Ulcerative colitis
2016 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry
1994
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Niacin therapy in atherosclerosis
2004
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
1999
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review
2006
A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions
2007
New Perspectives on the Use of Niacin in the Treatment of Lipid Disorders
2004
Clonal evolution in cancer
2012 StandoutNature
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Mass spectrometry‐based analytical tools for the molecular protein characterization of human plasma lipoproteins
2005
Valvular Heart Disease and Pregnancy
2005
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Safety Considerations with Niacin Therapy
2006
n-3 fatty acids and serum lipoproteins: human studies
1997
HeterogeneousHER2Gene Amplification
2011
Brain angiotensin receptor subtypes in the control of physiological and behavioral responses
1994
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes
2002
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
Ductal carcinoma in situ of the breast
1997
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology
2005 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
The Timing of Analysts' Earnings Forecasts
2010
Breast Cancer Treatment
2019 Standout
Niacin therapy in atherosclerosis
2005
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
1998 Standout
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
2008 Standout
Niacin, but Not Gemfibrozil, Selectively Increases LP-AI, a Cardioprotective Subfraction of HDL, in Patients With Low HDL Cholesterol
2001
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients
2009
Constructed Criteria
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
The Metabolic Syndrome
2008 Standout
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Trade Generation, Reputation, and Sell‐Side Analysts
2005
Angiogenesis in Endocrine Tumors
2003
Analyst Information Acquisition and Communication
2010
A Rational Expectations Theory of Kinks in Financial Reporting
2006
Different Gene Expression Patterns in Invasive Lobular and Ductal Carcinomas of the Breast
2004
The financial reporting environment: Review of the recent literature
2010 Standout
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Effects of Fluorination on Self-Assembled Monolayer Formation from Alkanephosphonic Acids on Aluminum: Kinetics and Structure
2003
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Works of John Morgan being referenced
External Quality Assurance of HER2 FISH and ISH Testing
2008
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme
2006
A Formalin-Fixed, Paraffin-Processed Cell Line Standard for Quality Control of Immunohistochemical Assay of HER-2/neu Expression in Breast Cancer
2002
A UK NEQAS ISH Multicenter Ring Study Using the Ventana HER2 Dual-Color ISH Assay
2010
The Effects of Niacin on Lipoprotein Subclass Distribution
2004
E-Cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast
1997
HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association
2008
Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing
2004
The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects*
1997
HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations
2008
Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction
2008
Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas
1997
Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin
1997
Rosuvastatin Alone or With Extended‐Release Niacin: A New Therapeutic Option for Patients With Combined Hyperlipidemia
2004
A new extended-release niacin (niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients
1998
A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma
1996
High-density lipoprotein subfractions and risk of coronary artery disease
2004
Effects of extended-release niacin on lipoprotein subclass distribution
2003
Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma
2001
Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the α3 nicotinic acetylcholine receptor subunit
2001
Niacin dosing: Relationship to benefits and adverse effects
2000
Possible role of tissue‐bound calcium ions in citrate‐mediated high‐temperature antigen retrieval
1994
Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels
2003
Precipitous labor in association with percutaneous mitral valvuloplasty: Successful delivery in the catheterization laboratory
2000
The clinical behavior of breast carcinoma is Probably determined at the preinvasive stage (Ductal carcinoma in Situ)
1997
The art of conversation: eliciting information from experts through multi-stage communication
2004
Sonication Assisted Growth of Fluorophosphate Films on Alumina Surfaces
2003
Epidermal Growth Factor Receptor Status in Hyperparathyroidism: Immunocytochemical and In Situ Hybridization Study
1996
The Effects of the Structured Interview on Reducing Biases Against Pregnant Job Applicants
2002
Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients With Hypercholesterolemia: A Placebo-controlled Trial.
1996
Angiotensin Injected into the Neostriatum After Learning Disrupts Retention Performance
1977 Science
Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
1994
Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients with Hypercholesterolemia: A Placebo-controlled Trial
1996
Information Aggregation in Polls
2008
An Analysis of Stock Recommendations
2003